281 related articles for article (PubMed ID: 28775165)
1. EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression.
Chen X; Ma H; Wang Z; Zhang S; Yang H; Fang Z
Cancer Res; 2017 Sep; 77(18):4998-5010. PubMed ID: 28775165
[TBL] [Abstract][Full Text] [Related]
2. Propofol enhances stem-like properties of glioma via GABA
Fan X; Gong M; Yu H; Yang H; Wang S; Wang R
Stem Cell Res Ther; 2022 Aug; 13(1):398. PubMed ID: 35927718
[TBL] [Abstract][Full Text] [Related]
3. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.
Kurtsdotter I; Topcic D; Karlén A; Singla B; Hagey DW; Bergsland M; Siesjö P; Nistér M; Carlson JW; Lefebvre V; Persson O; Holmberg J; Muhr J
Cancer Res; 2017 Sep; 77(18):4985-4997. PubMed ID: 28687615
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.
Ma L; Lin K; Chang G; Chen Y; Yue C; Guo Q; Zhang S; Jia Z; Huang TT; Zhou A; Huang S
Cancer Res; 2019 Jan; 79(1):72-85. PubMed ID: 30425057
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
Conde M; Michen S; Wiedemuth R; Klink B; Schröck E; Schackert G; Temme A
BMC Cancer; 2017 Dec; 17(1):889. PubMed ID: 29282022
[TBL] [Abstract][Full Text] [Related]
7. Loss of p53 Concurrent with RAS and TERT Activation Induces Glioma Formation.
Gong M; Fan X; Yu H; Niu W; Sun S; Wang H; Chen X
Mol Neurobiol; 2023 Jun; 60(6):3452-3463. PubMed ID: 36867344
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
9. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
10. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
11. TGF-β-activated lncRNA LINC00115 is a critical regulator of glioma stem-like cell tumorigenicity.
Tang J; Yu B; Li Y; Zhang W; Alvarez AA; Hu B; Cheng SY; Feng H
EMBO Rep; 2019 Dec; 20(12):e48170. PubMed ID: 31599491
[TBL] [Abstract][Full Text] [Related]
12. EZH2 is a potential prognostic predictor of glioma.
Chen YN; Hou SQ; Jiang R; Sun JL; Cheng CD; Qian ZR
J Cell Mol Med; 2021 Jan; 25(2):925-936. PubMed ID: 33277782
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
[TBL] [Abstract][Full Text] [Related]
14. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract][Full Text] [Related]
15. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis.
Wang H; Yin M; Ye L; Gao P; Mao X; Tian X; Xu Z; Dai X; Cheng H
Technol Cancer Res Treat; 2021; 20():15330338211011961. PubMed ID: 33902363
[TBL] [Abstract][Full Text] [Related]
16. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
18. EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis.
Zhao Y; Ding L; Wang D; Ye Z; He Y; Ma L; Zhu R; Pan Y; Wu Q; Pang K; Hou X; Weroha SJ; Han C; Coleman R; Coleman I; Karnes RJ; Zhang J; Nelson PS; Wang L; Huang H
EMBO J; 2019 Mar; 38(5):. PubMed ID: 30723117
[TBL] [Abstract][Full Text] [Related]
19. Functional roles of enhancer of zeste homolog 2 in gliomas.
Yin Y; Qiu S; Peng Y
Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
[TBL] [Abstract][Full Text] [Related]
20. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]